| Ytd | 1.01% | |
| 1y | -8.02% |
| Open | 53.20 | Prev Close | 54.28 | Low | 51.80 | High | 53.88 | Mkt Cap | 5.11B |
| Vol | 1.30M | Avg Vol | 1.62M | EPS | -4.76 | P/E | -11.13 | Forward P/E | -15.10 |
| Beta | 1.74 | Short Ratio | 11.23 | Inst. Own | 77.85% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-11 | 50-d Avg | 52.27 | 200-d Avg | 53.13 | 1yr Est | 87.56 |
CRSP News
Bank of America Corp DE lowered its position in shares of CRISPR Therapeutics AG (NASDAQ: CRSP) by 1
Antwerp, Belgium, August 10, 2026 - Agomab Therapeutics NV (Nasdaq: AGMB) ("Agomab" or the "Company"
CRISPR Therapeutics (CRSP) remains a "Strong Buy," supported by robust CASGEVY sales growth and pipe
CRSP reports a narrower-than-expected Q2 loss. Revenues beat estimates as Casgevy sales surge across
Citigroup analyst Yigal Nochomovitz maintains CRISPR Therapeutics (NASDAQ:CRSP) with a Buy and ra
CRISPR Therapeutics AG (CRSP) came out with a quarterly loss of $0.94 per share versus the Zacks Con
CRISPR Therapeutics (NASDAQ:CRSP) reported quarterly losses of $(0.94) per share which beat the anal
ZUG, Switzerland and BOSTON, Aug. 03, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) to
CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $48.44, moving +1.68% from the p
CRISPR Therapeutics recently won a key label expansion. The company has important data readouts on t
Analysts remain optimistic that the market will view upcoming catalysts in a bullish light.
Recently, Zacks.com users have been paying close attention to CRISPR Therapeutics (CRSP). This makes
CRISPR Therapeutics (CRSP) possesses the right combination of the two key ingredients for a likely e
In the most recent trading session, CRISPR Therapeutics AG (CRSP) closed at $46.54, indicating a -2.
Ark Investment Management's high-profile stock picker Cathie Wood has bought stakes in CRISPR Therap
Amova Asset Management Americas Inc. lessened its stake in CRISPR Therapeutics AG (NASDAQ: CRSP) by
CRISPR Therapeutics offers a diversified gene-editing pipeline, with CASGEVY as its lead approved as
Genomics is reshaping healthcare, and these three stocks - MYGN, SANA and WVE - stand out as rapid a
In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $47.78, marking a -1.63% move
CRISPR Therapeutics AG (CRSP) reached $48.57 at the closing of the latest trading day, reflecting a
Recently, Zacks.com users have been paying close attention to CRISPR Therapeutics (CRSP). This makes
CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $53.35, moving 5.31% from the pr
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
Stocks That Hit 52-Week Lows On Monday